• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-H180
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Stenosis (2263)
Event Type  Injury  
Manufacturer Narrative
Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus medical systems corp.(omsc) received a literature titled: "impact of a routine colorectal endoscopic submucosal dissection in the surgical management of nonmalignant colorectal lesions treated in a referral cancer center".¿literature summary¿ background this study evaluated the number of nonmalignant colorectal lesions referred to surgical treatment in a tertiary cancer center that incorporated magnification chromoendoscopy and endoscopic submucosal dissection as part of the standard management of complex colorectal polyps.Methods this single-center retrospective study, from a prospectively collected database, was conducted between january 2016 and december 2019 at the division of gastrointestinal surgery and division of endoscopy, instituto do câncer do estado de são paulo, a tertiary academic cancer center.Consecutive patients aged =18 year with complex nonmalignant colorectal polyps treated by esd or surgery (elective colectomy, rectosigmoidectomy, low anterior resection, or proctocolectomy) were included in this study.All procedures were performed under general anesthesia and under carbon dioxide insufflation.Results in the study period, 1.1% of 825 colorectal surgeries were performed for nonmalignant lesions, and 97 complex polyps were endoscopically removed by endoscopic submucosal dissection.The en bloc, r0, and curative resection rates of endoscopic submucosal dissection were 91.7%, 83.5%, and 81.4%, respectively.The mean tumor size was 59 (sd 37.8) mm.Perforations during endoscopic submucosal dissection occurred in 3 cases, all treated with clipping.One patient presented with a delayed perforation 2 days after the endoscopic resection and underwent surgery.The mean follow-up period was 3 years, with no tumor recurrence in this cohort.Conclusion a workflow that includes assessment of the lesions with magnification chromoendoscopy and resection through endoscopic submucosal dissection can lead to a very low rate of abdominal surgery for nonmalignant colorectal lesions.¿type of adverse events/number of patients¿ 1) event 1- perforations during procedure- 3 patients 2) event 2-perforation after surgery- 1 patient 3) event 3- stenosis- 4 patients perforations during endoscopic submucosal dissection occurred in 3 cases, which were managed endoscopically with clips.One patient developed delayed perforation after 2 days and underwent surgery.Four patients with lesions >110mm on the rectum developed stricture and were successfully treated with endoscopic dilations.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, a relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18763948
MDR Text Key336056311
Report Number9610595-2024-03792
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K100584
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-H180
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/03/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-